HC Wainwright Reaffirms Buy Rating for Precision BioSciences (NASDAQ:DTIL)
HC Wainwright reiterated their buy rating on shares of Precision BioSciences (NASDAQ:DTIL – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. HC Wainwright currently has a $60.00 price target on the stock. Separately, BMO Capital Markets upgraded shares of Precision BioSciences from a “market perform” rating to an “outperform” rating and […]
HC Wainwright reiterated their buy rating on shares of Precision BioSciences (NASDAQ:DTIL – Free Report) in a research note issued to investors on Wednesday,Benzinga reports. HC Wainwright currently has a $60.00 price target on the stock. Separately, BMO Capital Markets upgraded shares of Precision BioSciences from a “market perform” rating to an “outperform” rating and […]
